newsfilter
← Latest News
GlobeNewswire·

CervoMed to Participate in Upcoming Investor Conferences

BOSTON, March 05, 2026 (GLOBE NEWSWIRE) -- CervoMed Inc. (NASDAQ:CRVO), a clinical-stage biotechnology company developing treatments for age-related brain disorders, today announced that Company management will